Tatyana Beketova
Ophthalmology · Pittsburgh, PANPI 1366008575
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $2,303 of the $3,713 with a category attached, or 62.0%. 6 manufacturers reported payments, led by Bausch & Lomb Americas Inc. at 48.9% of the total. Reporting peaked in 2023 at $3,312 and has fallen 90.6% since, to $311 in 2025.
Across 31 payments — averaging $119.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bausch & Lomb Americas Inc.$2K
- Alcon$1K
- AbbVie$186
- Genentech USA, Inc.$150
- ANI Pharmaceuticals, Inc.$125
- AstraZeneca$15
What the payments were for
- Travel & lodging$2,30362%
- Food & beverage$1,41038%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bausch & Lomb Americas Inc. | 17 | $1,817 |
| Alcon | 4 | $1,421 |
| AbbVie | 7 | $186 |
| Genentech USA, Inc. | 1 | $150 |
| ANI Pharmaceuticals, Inc. | 1 | $125 |
| AstraZeneca | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- STELLARIS ELITE$1,121
- VABYSMO$150
- enVista MX60 IOL$143
- TORIC$143
- PURIFIED CORTROPHIN GEL$125
How this compares
$3,713 in reported general payments places this provider in the 75th percentile of 920 ophthalmology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Brimonidine Tartrate | 19 | $1,809 |
| Prednisolone Acetate | 18 | $1,091 |
| Timolol Maleate | 13 | $125 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Pittsburgh
- Francis MahPittsburgh$1.1M
- Robert NoeckerPittsburgh$632K
- Srinivas KondapalliPittsburgh$208K
- Deval ParanjpePittsburgh$121K
- Ian ConnerPittsburgh$82K
- Deepinder DhaliwalPittsburgh$65K
- Thomas FribergPittsburgh$55K
- Jenny YuPittsburgh$47K
- Vishal JhanjiPittsburgh$38K
- Omar AbbasiPittsburgh$36K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.